Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, July 2004, p. 2483-2489, Vol. 48, No. 7
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.7.2483-2489.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Candida glabrata erg1 Mutant with Increased Sensitivity to Azoles and to Low Oxygen Tension
Huei-Fung Tsai,1 Martin Bard,2 Koichi Izumikawa,1 Anna A. Krol,1 Aaron M. Sturm,2 Nicholas T. Culbertson,2 Charles A. Pierson,2 and John E. Bennett1*
Clinical Mycology Section, Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892,1
Department of Biology, Indiana University-Purdue University Indianapolis, Indianapolis, Indiana 462022
Received 8 January 2004/
Returned for modification 10 March 2004/
Accepted 18 March 2004
A Candida glabrata erg1 (Cgerg1) mutant, CgTn201S, was identified by transposon mutagenesis and by increased fluconazole susceptibility. CgERG1 encodes a 489-amino-acid protein which, on the basis of its homology with Saccharomyces cerevisiae ERG1, is a squalene epoxidase essential for ergosterol synthesis. Interruption following codon 475 of CgErg1p decreased the ergosterol content by 50%; caused accumulation of the squalene precursor; increased the levels of susceptibility to fluconazole, itraconazole, and terbinafine; increased the level of resistance to amphotericin B; increased the levels of rhodamine 6G and [3H]-fluconazole uptake; reduced the level of growth; and blocked growth under conditions of low oxygen tension. In addition, CgTn201S efficiently took up exogenous cholesterol from cholesterol-containing serum. Cholesterol constituted 34% of the extractable sterols in CgTn201S when it was grown aerobically on serum-containing medium. Under the same conditions, C. albicans contained only 0.1 to 1.2% cholesterol. Exogenous sterols also restored growth under conditions of low oxygen tension. Finally, complementation of the Cgerg1 mutation restored the levels of [3H]fluconazole uptake and drug susceptibility to wild-type levels.
* Corresponding author. Mailing address: Clinical Center, Room 11C304, NIH, Bethesda, MD 20892. Phone: (301) 496-3461. Fax: (301) 480-0050. E-mail:
Jbennett{at}niaid.nih.gov.
Antimicrobial Agents and Chemotherapy, July 2004, p. 2483-2489, Vol. 48, No. 7
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.7.2483-2489.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Sionov, E., Chang, Y. C., Garraffo, H. M., Kwon-Chung, K. J.
(2009). Heteroresistance to Fluconazole in Cryptococcus neoformans Is Intrinsic and Associated with Virulence. Antimicrob. Agents Chemother.
53: 2804-2815
[Abstract]
[Full Text]
-
Chauhan, N., Kruppa, M., Calderone, R.
(2007). The Ssk1p Response Regulator and Chk1p Histidine Kinase Mutants of Candida albicans Are Hypersensitive to Fluconazole and Voriconazole. Antimicrob. Agents Chemother.
51: 3747-3751
[Abstract]
[Full Text]
-
Vandeputte, P., Tronchin, G., Berges, T., Hennequin, C., Chabasse, D., Bouchara, J.-P.
(2007). Reduced Susceptibility to Polyenes Associated with a Missense Mutation in the ERG6 Gene in a Clinical Isolate of Candida glabrata with Pseudohyphal Growth. Antimicrob. Agents Chemother.
51: 982-990
[Abstract]
[Full Text]
-
Ruckenstuhl, C., Lang, S., Poschenel, A., Eidenberger, A., Baral, P. K., Kohut, P., Hapala, I., Gruber, K., Turnowsky, F.
(2007). Characterization of Squalene Epoxidase of Saccharomyces cerevisiae by Applying Terbinafine-Sensitive Variants. Antimicrob. Agents Chemother.
51: 275-284
[Abstract]
[Full Text]
-
Tsai, H.-F., Krol, A. A., Sarti, K. E., Bennett, J. E.
(2006). Candida glabrata PDR1, a Transcriptional Regulator of a Pleiotropic Drug Resistance Network, Mediates Azole Resistance in Clinical Isolates and Petite Mutants. Antimicrob. Agents Chemother.
50: 1384-1392
[Abstract]
[Full Text]
-
Liu, T. T., Lee, R. E. B., Barker, K. S., Lee, R. E., Wei, L., Homayouni, R., Rogers, P. D.
(2005). Genome-Wide Expression Profiling of the Response to Azole, Polyene, Echinocandin, and Pyrimidine Antifungal Agents in Candida albicans. Antimicrob. Agents Chemother.
49: 2226-2236
[Abstract]
[Full Text]
-
Pasrija, R., Krishnamurthy, S., Prasad, T., Ernst, J. F., Prasad, R.
(2005). Squalene epoxidase encoded by ERG1 affects morphogenesis and drug susceptibilities of Candida albicans. J Antimicrob Chemother
55: 905-913
[Abstract]
[Full Text]
-
Rogers, K. M., Pierson, C. A., Culbertson, N. T., Mo, C., Sturm, A. M., Eckstein, J., Barbuch, R., Lees, N. D., Bard, M.
(2004). Disruption of the Candida albicans CYB5 Gene Results in Increased Azole Sensitivity. Antimicrob. Agents Chemother.
48: 3425-3435
[Abstract]
[Full Text]